日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A decade of ibrutinib for CLL with and without TP53 aberration: final report on an investigator-sponsored phase 2 study

一项研究者发起的 II 期研究的最终报告:伊布替尼治疗伴或不伴 TP53 异常的慢性淋巴细胞白血病 (CLL) 十年的疗效

Itsara, Andy; Rogness, Victoria M; Samples, Laura; Yuan, Constance M; Wang, Hao-Wei; Ahn, Inhye E; Farooqui, Mohammed Z H; Tian, Xin; Sun, Clare; Tomasulo, Emily; Soto, Susan; Superata, Jeanine; Bezkorovaynaya, Larisa; Hughes, Thomas E; Nierman, Pia; Wiestner, Adrian

Potentiating CD20 monoclonal antibody therapy by targeting complement C3 fragments covalently deposited on lymphoma cells

通过靶向共价沉积在淋巴瘤细胞上的补体C3片段来增强CD20单克隆抗体疗法的疗效

Baskar, Sivasubramanian; Peng, Haiyong; Gaglione, Erika M; Carstens, Elizabeth J; Lindorfer, Margaret A; Ahn, Inhye E; Herman, Sarah E M; Skarzynski, Martin; Chang, Jing; Keyvanfar, Keyvan; Butera, Vicent; Blackburn, Amy; Vire, Bérengère; Maric, Irina; Stetler-Stevenson, Maryalice; Yuan, Constance M; Eckhaus, Michael A; Soto, Susan; Farooqui, Mohammed Z H; Taylor, Ronald P; Rader, Christoph; Wiestner, Adrian

Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice

慢性淋巴细胞白血病靶向治疗耐药性:现状及临床和诊断实践展望

Blombery, Piers; Chatzikonstantinou, Thomas; Gerousi, Marina; Rosenquist, Richard; Gaidano, Gianluca; Pospisilova, Sarka; Roberts, Andrew W; Birkinshaw, Richard W; Rossi, Davide; Scarfo, Lydia; Seymour, John F; Stilgenbauer, Stephan; Wiestner, Adrian; Woyach, Jennifer A; Brown, Jennifer R; Ghia, Paolo; Stamatopoulos, Kostas

Numbat-multiome: inferring copy number variations by combining RNA and chromatin accessibility information from single-cell data

Numbat-multiome:结合单细胞数据的RNA和染色质可及性信息推断拷贝数变异

Li, Ruitong; Alberge, Jean-Baptiste; Keshavarzian, Tina; Tsuji, Junko; Gustafsson, Johan; Rahmat, Mahshid; Lightbody, Elizabeth D; Deng, Stephanie L; Riviero, Santiago; Miller, Mendy; Naz Cemre Kalayci, F; Wiestner, Adrian; Sun, Clare; Lupien, Mathieu; Ghobrial, Irene; Parry, Erin; Gao, Teng; Getz, Gad

Automated and semi‐automated methods in quantitative and qualitative evaluation of the hippocampus

海马体定量和定性评估中的自动化和半自动化方法

Degheidy, Heba A; Venzon, David J; Farooqui, Mohammed Z H; Abbasi, Fatima; Arthur, Diane C; Wilson, Wyndham H; Wiestner, Adrian; Stetler-Stevenson, M A; Marti, Gerald E; Valentini, Bruna Bressan; Bieger, Andrei Sr; De Bastiani, Marco Antônio; Peixoto, Guilherme G Schu; Povala, Guilherme; Alves, Diego Moraes; Rigon, Fernando; Coutinho, Artur Martins; Souza, Laura Willers; Aranha, Mateus Rozalem; Rizzo, Marjana Reis Lima; Zimmer, Eduardo R; Borelli, Wyllians Vendramini

Resistance mechanisms and approach to chronic lymphocytic leukemia after BTK inhibitor therapy

BTK抑制剂治疗后慢性淋巴细胞白血病的耐药机制及治疗方法

Gruessner, Christine; Wiestner, Adrian; Sun, Clare

T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia

T-bet抑制慢性淋巴细胞白血病中恶性B细胞的增殖

Roessner, Philipp M; Seufert, Isabelle; Chapaprieta, Vicente; Jayabalan, Ruparoshni; Briesch, Hannah; Massoni-Badosa, Ramon; Boskovic, Pavle; Benckendorff, Julian; Roider, Tobias; Arseni, Lavinia; Coelho, Mariana; Chakraborty, Supriya; Vaca, Alicia M; Sivina, Mariela; Muckenhuber, Markus; Rodriguez-Rodriguez, Sonia; Bonato, Alice; Herbst, Sophie A; Zapatka, Marc; Sun, Clare; Kretzmer, Helene; Naake, Thomas; Bruch, Peter-Martin; Czernilofsky, Felix; Ten Hacken, Elisa; Schneider, Martin; Helm, Dominic; Yosifov, Deyan Y; Kauer, Joseph; Danilov, Alexey V; Bewarder, Moritz; Heyne, Kristina; Schneider, Christof; Stilgenbauer, Stephan; Wiestner, Adrian; Mallm, Jan-Philipp; Burger, Jan A; Efremov, Dimitar G; Lichter, Peter; Dietrich, Sascha; Martin-Subero, José I; Rippe, Karsten; Seiffert, Martina

Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application

分析 B 细胞急性淋巴细胞白血病中副胱天蛋白酶 MALT1 的活性,以用于潜在的靶向治疗应用

Firas M Safa, Terri Rasmussen, Lorena Fontan, Min Xia, Ari Melnick, Adrian Wiestner, Patricia Lobelle-Rich, Jan A Burger, Yara Mouawad, Hana Safah, Erik K Flemington, Nakhle S Saba

NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts

NRX-0492 可降解野生型和 C481 突变型 BTK,并在 CLL 患者来源的异种移植模型中显示出体内活性。

Deyi Zhang ,Hailey M Harris ,Jonathan Chen ,Jen Judy ,Gabriella James ,Aileen Kelly ,Joel McIntosh ,Austin Tenn-McClellan ,Eileen Ambing ,Ying Siow Tan ,Hao Lu ,Stefan Gajewski ,Matthew C Clifton ,Stephanie Yung ,Daniel W Robbins ,Mehdi Pirooznia ,Sigrid S Skånland ,Erika Gaglione ,Maissa Mhibik ,Chingiz Underbayev ,Inhye E Ahn ,Clare Sun ,Sarah E M Herman ,Mark Noviski ,Adrian Wiestner

CD49d Expression Identifies a Biologically Distinct Subtype of Chronic Lymphocytic Leukemia with Inferior Progression-Free Survival on BTK Inhibitor Therapy

CD49d表达可识别出一种生物学上独特的慢性淋巴细胞白血病亚型,该亚型在接受BTK抑制剂治疗后无进展生存期较差。

Alsadhan, Anfal; Chen, Jonathan; Gaglione, Erika M; Underbayev, Chingiz; Tuma, Pamela L; Tian, Xin; Freeman, Lita A; Baskar, Sivasubramanian; Nierman, Pia; Soto, Susan; Itsara, Andy; Ahn, Inhye E; Sun, Clare; Bibikova, Elena; Hartmann, Tanja Nicole; Mhibik, Maissa; Wiestner, Adrian